Your browser doesn't support javascript.
loading
Assessment of hearing screening programmes across 47 countries or regions II: coverage, referral, follow-up and detection rates from newborn hearing screening.
Mackey, Allison R; Bussé, Andrea M L; Hoeve, Hans L J; Goedegebure, André; Carr, Gwen; Simonsz, Huibert J; Uhlén, Inger M.
Affiliation
  • Mackey AR; CLINTEC, Karolinska Institutet, Stockholm, Sweden.
  • Bussé AML; Department of Otorhinolaryngology and Head and Neck Surgery and Department of Ophthalmology, Erasmus University Medical Center, Rotterdam, The Netherlands.
  • Hoeve HLJ; Department of Otorhinolaryngology and Head and Neck Surgery and Department of Ophthalmology, Erasmus University Medical Center, Rotterdam, The Netherlands.
  • Goedegebure A; Department of Otorhinolaryngology and Head and Neck Surgery and Department of Ophthalmology, Erasmus University Medical Center, Rotterdam, The Netherlands.
  • Carr G; Early Hearing Detection, Intervention and Family Centered Practice, London, UK.
  • Simonsz HJ; Department of Otorhinolaryngology and Head and Neck Surgery and Department of Ophthalmology, Erasmus University Medical Center, Rotterdam, The Netherlands.
  • Uhlén IM; CLINTEC, Karolinska Institutet, Stockholm, Sweden.
Int J Audiol ; 60(11): 831-840, 2021 11.
Article in En | MEDLINE | ID: mdl-33686919
ABSTRACT

OBJECTIVES:

To assess the performance of newborn hearing screening (NHS) programmes, through selected quality measures and their relationship to protocol design.

DESIGN:

NHS coverage, referral, follow-up and detection rates were aggregated. Referral rates were compared to age at screening step 1, number of steps, and test

method:

OAE or aABR. STUDY SAMPLE A questionnaire on existing hearing screening was completed by experts from countries in Europe, plus Russia, Malawi, Rwanda, India and China.

RESULTS:

Out of 47 countries or regions, NHS coverage rates were reported from 26, referral rates from 23, follow up from 12 and detection rates from 13. Median coverage rate for step 1 was 96%. Referral rate from step 1 was 6-22% where screening may be performed <24 h from birth, 2-15% for >24 h, and 4% for >72 h. Referral rates to diagnostic assessment averaged 2.1% after one to two steps using OAE only, 1.7% after two steps including aABR, and 0.8% after three to four steps including aABR. Median detection rate for bilateral permanent hearing impairment ≥40dB was 1 per 1000 infants.

CONCLUSION:

Referral rates were related to age, test method and number of screening steps. Quality measures were not available for many NHS programmes.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Evoked Potentials, Auditory, Brain Stem / Otoacoustic Emissions, Spontaneous Type of study: Diagnostic_studies / Guideline / Observational_studies / Prognostic_studies / Screening_studies Limits: Humans / Infant / Newborn Language: En Journal: Int J Audiol Journal subject: AUDIOLOGIA Year: 2021 Document type: Article Affiliation country: Sweden

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Evoked Potentials, Auditory, Brain Stem / Otoacoustic Emissions, Spontaneous Type of study: Diagnostic_studies / Guideline / Observational_studies / Prognostic_studies / Screening_studies Limits: Humans / Infant / Newborn Language: En Journal: Int J Audiol Journal subject: AUDIOLOGIA Year: 2021 Document type: Article Affiliation country: Sweden